Peter Lu, Partner and Global Head of the China Practice at McDermott Will & Emery, discusses China’s opening of its health industry to international investors.
Link established between western diets high in fat and sugar and the development of non-alcoholic fatty liver disease, the leading cause of chronic liver disease.
Delays in radiology are hamstringing the already overstretched NHS and prevent clinicians from providing timely diagnoses and treatment to their patients.
The priorities of Scottish Government Health Secretary Humza Yousaf MSP, especially elderly care and digital health, are underlined here by Open Access Government.
Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
British Skin Foundation walk us through the two main types of skin cancer, melanoma & non-melanoma, and the importance of funding research in the field.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, lifts the lid on predictive toxicology evolving from in vivo to in vitro to in silico systems starting with a look at organoids & organ-on-chip microfluidic devices.
